# US Cost Burden of Relapsed Refractory Multiple Myeloma during Third and Later Lines of Treatment

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/us-cost-burden-of-relapsed-refractory-multiple-myeloma-during-third-and-later/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Gene Felber,Chi‐Chang Chen,Jenny Willson,Chris Bell,Edgar P. Simard,Sasikiran Nunna,Chandrabhan Dharmani,Heide A. Stirnadel-Farrant,Rui Wang,Amanda Bruno |
| Citations | 6 |
| DOI | 10.1182/blood-2019-130791 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2984496311 |
| Type | conference-abstract |
| Year | 2019 |

## Paper authors

- [Sasikiran Nunna](https://scholariq.org/researchers/sasikiran-nunna/)

## Paper journal

- [Blood](https://scholariq.org/journals/blood/)

## Paper primary topic

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)

## Paper topics

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.